BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Drug Discovery





 Company News
Cytokinetics, Inc. (CYTK) To Present At The 34th Annual Canaccord Global Growth Conference 8/7/2014 2:03:46 PM
Cytokinetics, Inc. (CYTK) Announces Additional Data From BENEFIT-ALS To Be Presented At The 13th International Congress On Neuromuscular Diseases 7/3/2014 9:09:47 AM
Cytokinetics, Inc. (CYTK) Announces Data Relating To Tirasemtiv Presented At The 2014 Annual Spinal Muscular Atrophy Conference 6/16/2014 8:23:03 AM
Cytokinetics, Inc. (CYTK) Announces Further Results From BENEFIT-ALS Relating To Effects Following Withdrawal Of Tirasemtiv 6/2/2014 1:41:55 PM
Cytokinetics, Inc. (CYTK) To Hold Annual Meeting Of Stockholders 5/16/2014 12:08:35 PM
Bay Area's Cytokinetics, Inc. (CYTK) Plummets As ALS Drug Fails Phase 2B Study; Stock Down -64.67% At Market Close (April 25, 2014) 4/25/2014 6:42:00 AM
Amgen (AMGN), Cytokinetics, Inc. (CYTK) Heart Failure Drug Misses Phase 2 Goals; CYTK Stock Plummets -27.13% at Market Close (September 3, 2013) 9/3/2013 8:08:38 AM
Cytokinetics, Inc. (CYTK) Amends ALS Therapy Trial Design After Mistake 7/23/2013 7:32:35 AM
Cytokinetics, Inc. (CYTK) Says 58 in ALS Trial Got Placebo in Error 7/8/2013 8:15:51 AM
Astellas Pharma Inc. (YPH.BE), Cytokinetics, Inc. (CYTK) Ink $490 Million Muscle Biology Pact 6/25/2013 7:45:06 AM
12345678910...